Litigation Details for EPI Health, LLC v. Taro Pharmaceuticals, Inc. (D. Del. 2019)
✉ Email this page to a colleague
EPI Health, LLC v. Taro Pharmaceuticals, Inc. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-10-08 |
| Court | District Court, D. Delaware | Date Terminated | 2021-05-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Parties | TARO PHARMACEUTICALS, INC. | ||
| Patents | 10,335,391; 7,812,049; 8,420,688; 8,815,929; 8,883,838; 9,974,773 | ||
| Attorneys | Amy K. Wigmore | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in EPI Health, LLC v. Taro Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for EPI Health, LLC v. Taro Pharmaceuticals, Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-02 | 11 | Complaint - Amended | 929 patent”); 9,974,773 (the “’773 patent”); and 10,335,391 (the “’391 patent”). The ’049 patent, ’688… INFRINGEMENT OF U.S. PATENT NO. 10,335,391 75. Each of the preceding paragraphs…688 patent, ’929 patent, ’773 patent, and ’391 patent are collectively referred to herein as the “Patents-in-Suit…expiration of U.S. Patent Nos. 7,812,049 (the “’049 patent”); 8,420,688 (the “’688 patent”); 8,815,929 (the… This is an action for patent infringement arising under the patent laws of the United States, | External link to document |
| 2019-12-16 | 14 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,883,838 . (Poff, Adam) (Entered… 2019 24 May 2021 1:19-cv-01910 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-10-08 | 4 | Patent/Trademark Report to Commissioner of Patents | 8,420,688 B2; 8,815,929 B2; 9,974,773 B2; and 10,335,391 B2. (amf) (Entered: 10/09/2019) 8 October… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,812,049 B2; … 2019 24 May 2021 1:19-cv-01910 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-10-22 | 57 | Complaint - Amended | (the “’929 patent”); 9,974,773 (the “’773 patent”); 10,335,391 (the “’391 patent”), and 10,751,325 (the… INFRINGEMENT OF U.S. PATENT NO. 10,335,391 Each of the preceding paragraphs…(the “’325 patent”). The ’049 patent, ’688 patent, ’929 patent, ’773 patent, ’391 patent, and ’325 patent…expiration of U.S. Patent Nos. 7,812,049 (the “’049 patent”); 8,420,688 (the “’688 patent”); 8,815,929 (the… This is an action for patent infringement arising under the patent laws of the United States, | External link to document |
| 2020-10-22 | 58 | Patent/Trademark Report to Commissioner of Patents | B2 ;8,815,929 B2 ;8,883,838 B2 ;9,974,773 B2 ;10,335,391 B2 ;10,751,325 B2 . (Tigan, Jeremy) (Entered:… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,812,049 B2 ;… 2019 24 May 2021 1:19-cv-01910 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
